Introduction to ALS
JavaScript or Flash Player Not Detected
This ALS banner requires Flash player 7 or higher or javascript.
PLEASE NOTE:
As of November 23, 2009, ALS Canada has a new address and phone number:
3000 Steeles Avenue East, Suite 200
Markham, Ontario L3R 4T9
Phone: 905-248-2052   Fax: 905-248-2019

Introduction to ALS



  
 

  Wendy Johnston - Case Conundrums





Amyotrophic Lateral Sclerosis (ALS): The Diagnosis and Treatment of this Debilitating Disease

This article by Dr Andrew Eisen, Vancouver, BC, was originally published in Geriatrics and Aging
Originally published in: Volume 3, Number 9, November 2000
In 1869, french neurologist Jean-Martin Charcot first described a rapidly progressive, fatal neuromuscular disease. This disease, amyotrophic lateral sclerosis, or Lou-Gehrig's disease, is a neurodegenerative disorder that affects the patient's motor neurons; typically the patient is paralyzed or deceased within 2 to 5 years of the initial diagnosis. Currently, approximately 3000 Canadians suffer from this tragic disease.

Read Full Article

ALS/MND: The Dangers of Unproven "Therapies"
All of those involved in ALS/MND, be they health professionals, care-givers and, most of all, patients with ALS/MND are only too aware of the grave significance and implications of the disease. This results in a variable degree of desperation which makes all three vulnerable to “try anything” for “what is there to loose”? There are several categories of drug therapy.

Read Full article


Dr Heather Durham, a researcher in Montreal who is funded by our Neuroluscular Research Partnership, has kindly given us permission to post her presentation ALS RESEARCH - YESTERDAY, TODAY & TOMORROW. 
(It is a Power point presentation and requires Microsoft PowerPoint to view.)